XML 23 R12.htm IDEA: XBRL DOCUMENT
v3.21.2

Debt | 9 Months Ended
--- | ---
Sep. 30, 2021
Debt Disclosure [Abstract] |
Debt | Note 5 – Debt The following represents a summary of the Company’s notes payable – SBA government, loans payable – related parties, notes payable and convertible notes, key terms, and outstanding balances at September 30, 2021 and December 31, 2020, respectively: Notes Payable – SBA government (1) Paycheck Protection Program - PPP Loan Pertaining to the Company’s eighteen (18) month loan and in accordance with the Paycheck Protection Program (“PPP”) and Conditional Loan Forgiveness, the promissory note evidencing the loan contains customary events of default relating to, among other things, payment defaults, breach of representations and warranties, or provisions of the promissory note. The occurrence of an event of default may result in the repayment of all amounts outstanding, collection of all amounts owing from the Company, and/or filing suit and obtaining judgment against the Company. Under the terms of the PPP loan program, all or a portion of this Loan may be forgiven upon request from Borrower to Lender, provided the Loan proceeds are used in accordance with the terms of the Coronavirus Aid, Relief and Economic Security Act (the “Act” or “CARES”), Borrower is not in default under the Loan or any of the Loan Documents, and Borrower has provided documentation to Lender supporting such request for forgiveness that includes verifiable information on Borrower’s use of the Loan proceeds, to Lender’s satisfaction, in its sole and absolute discretion. SURGEPAYS, INC. AND SUBSIDIARIES NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS SEPTEMBER 30, 2021 (2) Economic Injury Disaster Loan (“EIDL”) This program was made available to eligible borrowers in light of the impact of the COVID-19 pandemic and the negative economic impact on the Company’s business. Proceeds from the EIDL are to be used for working capital purposes. Installment payments, including principal and interest, are due monthly (beginning twelve (12) months from the date of the promissory note) in amounts ranging from $109 - $751/month. The balance of principal and interest is payable over the next thirty (30) years from the date of the promissory note. There are no penalties for prepayment. Based upon guidance issued by the SBA on June19, 2020, the EIDL Loan is not required to be refinanced by the PPP loan. Schedule of Notes Payable
|  | PPP |  |  | EIDL |  |  | EIDL |  |  | PPP |
Terms |  | SBA |  |  | SBA |  |  | SBA |  |  | SBA |
Issuance dates of SBA loans |  |  | April 2020 |  |  |  | May 2020 |  |  |  | July 2020 |  |  |  | March 2021 |
Term |  |  | 18 months |  |  |  | 30 Years |  |  |  | 30 Years |  |  |  | 5 Years |
Maturity date |  |  | October 2021 |  |  |  | May 2050 |  |  |  | July 2050 |  |  |  | March 2026 |
Interest rate |  |  | 1% |  |  |  | 3.75% |  |  |  | 3.75% |  |  |  | 1% |
Collateral |  |  | Unsecured |  |  |  | Unsecured |  |  |  | Unsecured |  |  |  | Unsecured |
Conversion price |  |  | N/A |  |  |  | N/A |  |  |  | N/A |  |  |  | N/A |
|  |  |  |  |  |  |  |  |  |  |  |  |  | Total |
Principal |  | $ | 498,082 |  |  | $ | 150,000 |  |  | $ | 486,600 |  |  | $ | 518,167 |  |  | $ | 1,652,849 |
Balance - December 31, 2019 |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Gross proceeds |  |  | 498,082 |  |  |  | 150,000 |  |  |  | 486,600 |  |  |  | - |  |  |  | 1,134,682 |
Balance - December 31, 2020 |  |  | 498,082 |  |  |  | 150,000 |  |  |  | 486,600 |  |  |  | - |  |  |  | 1,134,682 |
Gross proceeds |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 518,167 |  |  |  | 518,167 |
Deconsolidation of subsidiary (“TW”) |  |  | - |  |  |  | - |  |  |  | (150,000 | )* |  |  | - |  |  |  | (150,000 | )
Repayments |  |  | - |  |  |  | (1,040 | ) |  |  | (2,385 | ) |  |  | - |  |  |  | (3,425 | )
Balance - September 30, 2021 |  | $ | 498,082 |  |  | $ | 148,960 |  |  | $ | 334,215 |  |  | $ | 518,167 |  |  | $ | 1,499,424 |
* | In connection with the deconsolidation of TW, $150,000 was assumed by the buyer.
SURGEPAYS, INC. AND SUBSIDIARIES NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS SEPTEMBER 30, 2021 Notes Payable – Related Parties Schedule of Notes Payable
|  | 1 |  | 2
|  | Note Payable |  | Note Payable
Terms |  | Related Party |  | Related Party
Issuance dates of notes |  | Various |  | May 2020/January 2021
Maturity date |  | June 30, 2022 or January 1, 2023 due on demand |  | March 2021 and due on demand
Interest rate |  | 10% |  | 15%
Collateral |  | Unsecured |  | Unsecured
Conversion price |  | N/A |  | N/A
|  |  |  |  |  |  |  | Total |  |  | In-Default |
Balance - December 31, 2019 |  |  | 2,205,440 |  |  |  | - |  |  |  | 2,205,440 |  |  | $ | - |
Gross proceeds |  |  | 1,136,500 |  |  |  | 147,500 |  |  |  | 1,284,000 |  |  |  |  |
Balance - December 31, 2020 |  |  | 3,341,940 |  |  |  | 147,500 |  |  |  | 3,489,440 |  |  |  | - |
Gross proceeds |  |  | 3,625,000 |  |  |  | 63,000 |  |  |  | 3,688,000 |  |  |  |  |
Repayments |  |  | - |  |  |  | (163,000 | ) |  |  | (163,000 | ) |  |  |  |
Balance - September 30, 2021 |  | $ | 6,966,940 |  |  | $ | 47,500 |  |  | $ | 7,014,440 |  |  | $ | - |
1 | Activity is with the Company’s Chief Executive Officer and Board Director (Kevin Brian Cox). Prior to September 30, 2021, these notes were either due on demand or had a specific due date. Additionally, these advances had interest rates from 6%-15%. On September 30, 2021, all notes and related accrued interest were combined into two (2) new notes. The new notes had due dates of June 30, 2022 or January 1, 2023. All notes bear interest at 10%.
2 | Activity is with the Company’s President, Chief Operating Officer and Board Director (Anthony Nuzzo). In 2021, the Company received advances of $63,000 in the quarter ended March 31, 2021, which were repaid in the quarter ended March 31, 2021 (this related to the January 2021 note). The remaining outstanding amount of $47,500 is due on demand.
On November 4, 2021, the Company’s Chief Executive Officer converted notes totaling $2,415,560 into 561,758 shares of common stock, having a fair value of $1,808,861 ($3.22/share), based upon the quoted closing trading price. As a result of the debt conversion, the Company recognized a gain on debt extinguishment of $605,699. However, since this is a related party transaction, accordingly no gain can be recognized, resulting in an increase to additional paid-in capital. SURGEPAYS, INC. AND SUBSIDIARIES NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS SEPTEMBER 30, 2021 Notes Payable Schedule of Notes Payable
Terms |  | Note |  | Note |  | Note |  | Notes
Issuance dates of notes |  | 2016 |  | 2016 |  | November 4, 2019 |  | August/September 2021
Maturity date |  | 2016 |  | 2017 |  | November 3, 2020 |  | August/September 2022
Interest rate |  | 5% |  | 10% |  | 18% |  | 10%
Collateral |  | Unsecured |  | Unsecured |  | Unsecured |  | Unsecured
Conversion price |  | N/A |  | N/A |  | N/A |  | N/A
Warrants issued as discount |  | N/A |  | N/A |  | N/A |  | 2,406,250
|  |  |  |  |  |  |  |  |  |  |  |  |  | Total |  |  | In-Default |
Principal |  | $ | 485,000 |  |  | $ | 27,500 |  |  | $ | 250,000 |  |  | $ | 853,386 | * |  | $ | 1,615,886 |  |  |  |  |
Balance - December 31, 2019 |  |  | 485,000 |  |  |  | 27,500 |  |  |  | 223,672 |  |  |  | - |  |  |  | 736,172 |  |  | $ | 512,500 |
Amortization of debt discount |  |  | - |  |  |  | - |  |  |  | 26,328 |  |  |  | - |  |  |  | 26,328 |  |  |  |  |
Repayments |  |  | (485,000 | ) |  |  | (27,500 | ) |  |  | - |  |  |  | - |  |  |  | (512,500 | ) |  |  |  |
Balance - December 31, 2020 |  |  | - |  |  |  | - |  |  |  | 250,000 |  |  |  | - |  |  |  | 250,000 |  |  |  | 250,000 |
Gross proceeds |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 853,386 |  |  |  | 853,386 |  |  |  |  |
Debt discount |  |  | - |  |  |  | - |  |  |  | - |  |  |  | (265,268 | )** |  |  | (265,268 | ) |  |  |  |
Amortization of debt discount |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 5,087 |  |  |  | 5,087 |  |  |  |  |
Repayments |  |  | - |  |  |  | - |  |  |  | (250,000 | ) |  |  | - |  |  |  | (250,000 | ) |  |  |  |
Balance - September 30, 2021 |  | $ | - |  |  | $ | - |  |  | $ | - |  |  | $ | 593,205 |  |  | $ | 593,205 |  |  | $ | - |
* | In the event of default, notes with principal totaling $386,000 are convertible at 75% of the market price based upon the VWAP in preceding 10 days.
** | Debt discount on notes totaling $386,000 includes original issue discounts of $36,000 and debt discounts associated with warrants totaling $229,268.
Subsequent to September 30, 2021, the Company repaid $386,000 and related accrued interest of $5,016. At this time the remaining debt discount was fully amortized to interest expense. SURGEPAYS, INC. AND SUBSIDIARIES NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS SEPTEMBER 30, 2021 Convertible Notes Payable – Net Schedule of Notes Payable
Terms |  | Notes Payable |  | Notes Payable |  | Notes Payable
Issuance dates of notes |  | 2019 and Prior |  | February 2020 - December 2020 |  | January 2021 - March 2021
Maturity date |  | 2020 |  | February 2021 - September 2021 |  | May 2021 - March 2022
Interest rate |  | 14% |  | 10% - 14% |  | 5% - 12%
Collateral |  | Unsecured |  | Unsecured |  | Unsecured
Conversion price |  | A |  | A |  | B
|  |  |  |  |  |  |  |  |  |  | Total |  |  | In-Default |
Principal |  | $ | - |  |  | $ | 2,347,000 |  |  | $ | 2,550,000 |  |  | $ | 4,897,000 |  |  |  |  |
Balance - December 31, 2019 |  | $ | 4,436,684 |  |  | $ | - |  |  | $ | - |  |  | $ | 4,436,684 |  |  | $ | - |
Gross proceeds |  |  | - |  |  |  | 2,347,000 |  |  |  | - |  |  |  | 2,347,000 |  |  |  |  |
Debt discount |  |  | - |  |  |  | (2,347,000 | ) |  |  | - |  |  |  | (2,347,000 | ) |  |  |  |
Amortization of debt discount |  |  | 161,217 |  |  |  | 1,829,219 |  |  |  | - |  |  |  | 1,990,436 |  |  |  |  |
Repayments - cash |  |  | (438,698 | ) |  |  | (130,061 | ) |  |  | - |  |  |  | (568,759 | ) |  |  |  |
Repayments - common stock |  |  | (4,159,203 | ) |  |  | (182,988 | ) |  |  | - |  |  |  | (4,342,191 | ) |  |  |  |
Balance - December 31, 2020 |  |  | - |  |  |  | 1,516,170 |  |  |  | - |  |  |  | 1,516,170 |  |  |  | - |
Gross proceeds |  |  | - |  |  |  | - |  |  |  | 2,550,000 |  |  |  | 2,550,000 |  |  |  |  |
Debt discount |  |  | - |  |  |  | - |  |  |  | (2,460,829 | ) |  |  | (2,460,829 | ) |  |  |  |
Amortization of debt discount |  |  | - |  |  |  | 517,781 |  |  |  | 1,458,912 |  |  |  | 1,976,693 |  |  |  |  |
Repayments - cash |  |  | - |  |  |  | (1,132,170 | ) |  |  | (250,000 | ) |  |  | (1,382,170 | ) |  |  |  |
Repayments - common stock |  |  | - |  |  |  | (978,728 | ) |  |  | - |  |  |  | (978,728 | ) |  |  |  |
Reclassified to receivable |  |  | - |  |  |  | 76,947 | C |  |  | - |  |  |  | 76,947 |  |  |  |  |
Balance - September 30, 2021 |  | $ | - |  |  | $ | - |  |  | $ | 1,298,083 |  |  | $ | 1,298,083 |  |  | $ | - |
A | - Convertible at 65% multiplied by the lowest one (1) day volume weighted average price (“VWAP”) of the Company’s common stock during the ten (10) trading days prior to conversion.
B | - Convertible at 70% - 75% multiplied by the lowest one (1) day volume weighted average price (“VWAP”) of the Company’s common stock during the ten (10) trading days prior to conversion.
C | - During 2021, the Company overpaid a note holder by $76,947 when settling the outstanding balance. This overpayment had been recorded as a receivable and was repaid in full in April 2021.
SURGEPAYS, INC. AND SUBSIDIARIES NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS SEPTEMBER 30, 2021 Line of Credit The Company had a $1,000,000 line of credit with a bank, bearing interest at 6%, which was due in April 2021. The line of credit was secured by all of the Company’s assets and was personally guaranteed by the owner of the majority of the Company’s voting shares. The balance at September 30, 2021 and December 31, 2020 was $0 and $912,870. In connection with the deconsolidation of TW in May 2021, the buyer assumed the line of credit.

X
- References No definition available. + Details
Name: | us-gaap_DebtDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -URI http://asc.fasb.org/topic&trid=2208564 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1B -Subparagraph (h) -URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1C -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1I -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1I -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(c)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1B -Subparagraph (g) -URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1C -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1C -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1E -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1B -URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1I -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1B -Subparagraph (i) -URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611 + Details
Name: | us-gaap_DebtDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration